News

R-Tech Ueno will use Albucult as a major component in its new therapy to treat severe and moderate dry eye conditions. Albucult is believed to confer many advantages

As per the deal, Gilead will be responsible for the formulation, manufacturing, registration, distribution and commercialisation of the single-tablet regimen worldwide, while Tibotec will co-detail the single-tablet regimen

The investment is intended for the manufacturing of the antidepressant Seroxat and the HIV treatment Retrovir, business-review.ro reported. The site has quoted GSK Romania general manager Pascal Prigent

A research proposal with total funding of $33.1m involving a collaboration among CureVac, Sanofi Pasteur and In-Cell-Art, a French biotech company contributing its nanoparticle technology, has been selected

The collaboration is believed to make use of the academic and clinical research strengths of both Canada and the UK to drive the research on innovative alternatives to

The project commenced after the biology team at the DDU screened one of their collections of compounds against the malaria parasite, healthcanal.com reported. Over a span of 18

Words+ is known to provide products and services and is commited to the field of augmentative communication. Simulations Plus chairman and CEO Walt Woltosz said Words+ provides computer-based

Scil Proteins took up the process development and early stage GMP manufacturing for a recombinant protein candidate. Scil Proteins CEO Ulrike Fiedler said the company is happy that

Fibrocaps is a dry powder topical fibrin sealant comprising of a mixture of fibrinogen and thrombin blood clotting proteins, which stop bleeding during or after surgery. The study